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Background: The cardioprotective effect of propofol on ischemia-reperfusion injury
(I/R injury) is partly due to suppressing apoptosis. Mitochondrial dynamics are
also involved in apoptosis. Mitochondrial fusion and fission lead to mitochondrial
morphological changes. However, whether suppressing apoptosis effect of propofol
against ischemia-reperfusion injury in the heart is via regulating mitochondrial
morphology remains unclear.
Methods: H9c2 cells underwent oxygen glucose deprivation (OGD) followed by
reperfusion to simulate cardiomyocytes ischemia/reperfusion injury. Cell viability,
apoptosis ratio and intracellular reactive oxygen species (ROS) were assessed,
respectively. Mitochondrial membrane dynamin family proteins, extracellular signal
regulated kinase 1 and 2 (ERK1/2), phosphorylated extracellular signal regulated
kinase 1 and 2 (p-ERK1/2) and proteins related to intrinsic apoptosis pathways were
detected by western blotting. The mitochondrial morphology and the distribution of
dynamin-related protein 1 (Drp1) were observed by using laser confocal microscopy.
Results: Propofol enhanced the survival of H9c2 cells, decreased ROS levels and
inhibited apoptosis during oxygen glucose deprivation/reperfusion (OGD/R) injury.
Mitochondrial fission in H9c2 cells was inhibited by propofol during OGD injury. Propofol
alleviated high levels of mitochondrial fusion and fission during OGD/R in H9c2 cells,
by regulating mitochondrial membrane remodeling dynamin family proteins. Propofol
inhibited Drp1 colocalization with mitochondria in H9c2 cells during OGD/R injury.
Moreover, Drp1 phosphorylation was inhibited by propofol through decreasing ERK
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activation during OGD/R injury. We found that propofol ameliorated H9c2 cells apoptosis
during OGD/R via inhibiting mitochondrial cytochrome c release and caspase-9,
caspase-6, caspase-7 and caspase-3 activation.
Conclusion: Propofol suppresses H9c2 cells apoptosis during OGD/R injury via
inhibiting intrinsic apoptosis pathway, which may be partly due to reducing high levels
of mitochondrial fusion and fission induced by OGD/R injury.
Keywords: propofol, ischemia, reperfusion, mitochondrial dynamics, apoptosis
INTRODUCTION
The intravenous anesthetic propofol (2, 6-diisopropylphenol) is
widely used in anesthesia and sedation due to the rapid induction
and recovery from anesthesia (Wahr et al., 2000). Many lines of
evidence indicate that propofol exhibits cardioprotective effects
(Kokita and Hara, 1996; Xia et al., 2003). As for the mechanism,
similar to vitamin E, propofol contains a phenolic hydroxyl
group, which has been associated with its antioxidant effect
(Vasileiou et al., 2009). Researches indicate that propofol can
scavenge the free radical, both in vitro and in vivo (Li et al., 2012),
thus ameliorating ischemic myocardial contractile dysfunction
and arrhythmias (Hanouz et al., 2003), narrowing infarct size, and
reducing tissue lesions (Ko et al., 1997). Moreover, propofol has
been shown to attenuate ischemia-reperfusion injury (I/R injury)
by suppressing apoptosis and preserving mitochondrial function
(Jin et al., 2009), but the exact mechanism remains unclear.
Mitochondria are the most important sources of energy in
the heart, providing over 90% adenosine triphosphate (ATP)
to the heart through oxidative phosphorylation (Schaper et al.,
1985). In addition, mitochondria also play a key role in
regulating apoptosis and cell growth, and in generating reactive
oxygen species (ROS). Additionally, mitochondrial morphology
is now recognized as an important factor closely associated with
the energetic state of mitochondria (Galloway et al., 2012b).
Mitochondrial morphology varies among different cell types.
Mitochondria are in the process of continuous fission and fusion
mediated by membrane remodeling dynamin family proteins
(Ishihara et al., 2009). When oxidative stress occurs during
acute I/R injury, mitochondrial fission can be caused in HL-1
cardiac cells (Ong et al., 2010). Dynamin family proteins involve
mitofusin 1 (Mfn1), mitofusin 2 (Mfn2) and optic atrophy
1 (Opa1) protein that mediate mitochondrial fusion, whereas
dynamin-related protein (Drp1) and fission 1 (Fis1) protein
regulate mitochondrial fission.
Cardiomyocyte apoptosis plays an essential role in acute
myocardial ischemia-reperfusion injury (I/R injury) (Haunstetter
and Izumo, 1998). Apoptosis can be regulated through
both intrinsic and extrinsic pathways (Zhang et al., 2002).
Mitochondrial-shaping proteins are involved in intrinsic
apoptosis pathway (Ong et al., 2017). They play important
roles in the mitochondrial outer membrane permeabilization
(MOMP) and the release of apoptotic factors, for example,
cytochrome c release (Montessuit et al., 2010). However, whether
suppressing apoptosis effect of propofol against ischemia-
reperfusion injury (I/R injury) in the heart is via an intrinsic
mitochondrial mechanism remains unclear. Based on previous
studies, we hypothesize that propofol may reduce cardiomyocyte
apoptosis induced by acute ischemia-reperfusion injury (I/R
injury), via an intrinsic mitochondrial mechanism, by regulating
mitochondrial fusion and fission. In this study, we used the H9c2
cell line subjected to oxygen glucose deprivation (OGD) followed
by reperfusion (OGD/R) as an in vitro model of cardiomyocytes
ischemia and investigated the underlying mechanism of propofol
against cells apoptosis.
MATERIALS AND METHODS
Cell Culture and Reagents
The H9c2 cells, a cardiomyocyte cell line, were purchased from
the Shanghai Institute for Biological Sciences, Chinese Academy
of Sciences (Shanghai, China). Dulbecco’s modified Eagle’s
medium/F-12 (DMEM/F-12) and fetal bovine serum (FBS)
were both purchased from Gibco-Invitrogen (Grand Island,
NY, United States). The cells were cultured in DMEM/F-12,
supplemented with 10% FBS and 1% penicillin/streptomycin at




H9c2 cells were incubated with a normal medium in a cell
incubator for 24 h. Cells were then exposed to hypoxic
conditions (oxygen deprivation, 1% O2) for 24 h in a culture
medium with lower glucose and 1% FBS. After hypoxia, the
cells were oxygenated under a normal oxygen concentration
(reoxygenation) for 24 h in a normal medium. According to
the previous study, propofol (Sigma-Aldrich, United States) was
added respectively to the cells 1 h before and during the hypoxia-
reoxygenation with different concentrations (5, 10, and 20 µM)
(Zhao et al., 2015). U0126 (Beyotime, Haimen, China), MEK1/2
inhibitor, was added to the cells during OGD/R at a concentration
of 20 µM. After H9c2 cells were incubated with a normal medium
in cell incubator for 24 h, propofol and caspase inhibitor Z-VAD-
FMK (Beyotime, Haimen, China) were respectively added to the
cells for 24 h.
Cell Viability Assay
Cell viability was measured by a cell counting kit-8 (CCK-8),
purchased from Tokyo, Japan. Cells were seeded in 96-well cell
culture plates at a density of 2 × 104 cells/well. After 24 h
in the culture, cells were added with different concentrations
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of propofol for hypoxia-oxygenation or just were respectively
added with different concentrations of propofol and Z-VAD-
FMK. Then, the supernatant fluid was removed and a medium
containing 10% CCK- 8 reagent was added for 1–3 h incubation
at 37◦C. Eventually, the absorbance at 450 nm was measured
using an AMR-100 automatic enzyme analyzer (Allsheng,
Hangzhou, China).
Intracellular ROS Detection
In order to detect intracellular ROS, the cells were preloaded with
10 µM 2, 7-dichlorofluorescin diacetate (DCFH-DA, Beyotime,
Haimen, China) for 20 min at 37◦C. Afterward, the cells were
washed using a culture medium without serum for at least three.
A fluorescence microplate reader with an excitation wavelength
of 488 nm and an emission wavelength of 525 nm was used to
determine the intensity of DCF fluorescence.
Cell Apoptosis Assay
Cells were seeded into a 6-well cell culture plate and an
established OGDR model, and treated with propofol. The
FITC Annexin V Apoptosis Detection Kit (BD PharmingenTM,
United States) was used to detect apoptotic cells according to
the manufacturer’s protocol. First, cells were washed twice with
cold PBS and then cells were resuspended in a 1X Binding Buffer
at a concentration of 1 × 10ˆ6 cells/ml. Second, 100 µl of the
solution (1 × 10ˆ5 cells) was transferred to a 5 ml culture tube.
Third, 5 µl of FITC Annexin V and 5 µl PI was added. Fourth,
the cell were gently vortexed and incubated for 15 min at room
temperature (25◦C) in the dark. Fifth, 400 µl of the 1X Binding
Buffer was added to each tube. Lastly, the cells were analyzed via
flow cytometry within 1 h. The proportion of apoptotic cells was
calculated by FlowJo software.
Confocal Laser Scanning Fluorescence
Microscopy
Confocal fluorescence microscopy was performed using a Laser
Scanning Confocal Microscope (TCS SP5; Leica Microsystems,
Inc., United States). After cells climbed to the carry sheet glass,
we established an OGDR model and treated cells with propofol.
The cells were then incubated for 15 min at room temperature
with a 100 nM Mito-Tracker Red (Invitrogen, United States)
to stain the mitochondrial membrane. Cells were fixed in 4%
paraformaldehyde for 15 min and blocked with 5% bovine serum
albumin (BSA) for 2 h, and then permeabilized with Triton-X 100
(0.1%) for 15 min. Cells were incubated with the primary mouse
anti-Drp1 antibody (1:100) (BD Biosciences, United States) at
4◦C overnight, washed with cold PBS, and incubated with
Fluorescein-conjugated anti-mouse secondary antibody (1:100)
(Proteintech, Wuhan, China) for 2 h at room temperature. The
cells were then imaged at x630 magnification. Image J software
was used to analyze the mitochondrial fragmentation count.
Mitochondria/Cytosol Fractionation
This assay was conducted using a Mitochondrial Isolation
Kit (Pierce, Rockford, IL, United States) according to the
manufacturers’ protocol. Cells were homogenized and the
homogenates were centrifuged at 750 g for 10 min at 4◦C. The
pellet was kept as a mitochondrial fraction. The supernatant
was centrifuged at 12,000 g for 15 min at 4◦C. The supernatant
was further centrifuged at 100,000 g for 1 h, and the
supernatant was kept as the cytosol fraction. Cytochrome c in
cytoplasm or mitochondria was detected with an immunoblot
analysis, respectively.
Western Blotting
Cell lysates were separated on 6, 10, 12% SDS-PAGE, and
transferred to polyvinylidene difluoride membranes (PVDF,
Millipore, Billerica, MA, United States). The membranes were
blocked and incubated with primary antibodies against anti-
Drp1 (1:1000, BD Biosciences, United States), anti-pDrp1
(1:1000, CST, United States), anti-Fis1 (1:1000, Proteintech,
China), anti-Mfn1 (1:1000, Proteintech, China), anti-Mfn2
(1:1000, CST, United States), anti-Opa1 (1:1000, BD Biosciences,
United States), anti-ERK (1:1000, CST, United States), anti-
pERK (1:1000, CST, United States), anti-Cytochrome c (1:1000,
CST, United States), anti-Bax (1:1000, CST, United States),
anti-Bak (1:1000, CST, United States), anti-Apaf1 (1:1000,
Proteintech, China), anti-Caspase 9 (1:1000, CST, United States),
anti-Caspase 6 (1:1000, CST, United States), anti-Caspase
7 (1:1000, CST, United States), anti-Caspase3 (1:1000, CST,
United States), anti-COX IV (1:1000, CST, United States) and
anti-GAPDH (1:1000, CST, United States) at 4◦C overnight.
After primary antibody incubation, the membranes were
incubated with either goat anti-mouse or goat anti-rabbit
horseradish peroxidase-conjugated secondary antibodies, at
room temperature for 2 h. Immunoreactive bands were
developed with an electrochemiluminescence (ECL) reagent
(Thermo-Pierce, Rockford, IL, United States). Images were
quantified using Gel-Pro Analyzer software (Media Cybernetics,
Silver Spring, MD, United States).
Statistical Analysis
The results were presented as the mean ± standard deviation
(SD). Statistical analysis was performed using the software
Statistical Package for the Social Science (SPSS, Chicago, IL,
United States). The analysis of variance (ANOVA) was used for
comparisons among groups and differences with a P < 0.05, were
considered statistically significant.
RESULTS
Propofol Enhanced the Survival of H9c2
Cells and Decreased the ROS Level
Against OGD/R Injury. Moreover, the
H9c2 Cells Proliferation Under Normal
Culture Conditions Was Inhibited by
Propofol and Caspase Inhibitor Relieved
the Effect of Propofol
Compared with the control group, cell viability was significantly
decreased in the OGD/R group without propofol. But as the
Frontiers in Pharmacology | www.frontiersin.org 3 February 2019 | Volume 10 | Article 61
fphar-10-00061 February 8, 2019 Time: 19:36 # 4
Zhao et al. Propofol Maintains Mitochondrial Dynamic Homeostasis
FIGURE 1 | Propofol enhanced the survival of H9c2 cells and decreased ROS level against OGD/R injury. Moreover, H9c2 cells proliferation under normal culture
conditions was inhibited by propofol and caspase inhibitor relieved the effect of propofol. (A,C) Cell viability was assessed by measuring the CCK8. The viability of
control group was defined as 100%. (B) Effects of propofol (5, 10, and 20 µM) on increased intracellular ROS induced by OGD/R in H9c2 cells. The ROS contents of
control group was defined as 100. The results were shown as mean ± SD from at least three independent experiments. ∗P < 0.05, ∗∗P < 0.01 versus control,
#P < 0.05, ##P < 0.01 versus OGD/R group without propofol, 1P < 0.05 versus 20 µM propofol group.
concentration of propofol (5, 10, and 20 µM) went up, H9c2
cells survival increased compared with the OGD/R group without
propofol (Figure 1A). In this experiment, OGD/R obviously
elevated the intracellular ROS level compared with control
group. Interestingly, compared with the OGD/R group without
propofol, the ROS level was obviously inhibited with the
increasing dose of propofol (5, 10, and 20 µM) (Figure 1B).
These results demonstrated that propofol inhibited cell death and
decreased the intracellular ROS level induced by OGD/R in the
H9c2 cells. Moreover, propofol (10 and 20 µM) inhibited the
H9c2 cells proliferation under normal culture conditions and
Z-VAD-FMK could relieve the decrease of cell viability induced
by 20 µM propofol (Figure 1C). These results demonstrated that
high concentrations of propofol could cause damage to the H9c2
cells by activating caspases.
Propofol Inhibited Cell Apoptosis
Induced by OGD/R in H9c2 Cells
Cardiomyocyte apoptosis in acute myocardial ischemia-
reperfusion injury could be one of the main mechanisms.
The results of the present study demonstrated that H9c2
cell apoptosis in the OGD/R group without propofol, was
significantly increased compared with the control group.
Compared with the OGD/R group without propofol, propofol
alleviated H9c2 cell apoptosis induced by OGD/R, in a dose-
dependent manner, at the range of 5∼20 µM (Figure 2). These
results were consistent with a previous report that propofol
could attenuate cardiomyocytes apoptosis induced by H2O2
(Liu et al., 2017).
Propofol Inhibited Mitochondrial Fission
in H9c2 Cells During OGD Injury
When oxidative stress occurs during acute I/R injury,
mitochondrial fission can be caused in HL-1 cardiac cells (Ong
et al., 2010). Compared with the control group, mitochondrial
fragmentation was obvious, and the quantity of mitochondria
increased in H9c2 cells during OGD injury (Figures 3A,B,D,E).
Compared with the OGD group without propofol, propofol
(20 µM) significantly inhibited mitochondrial fission and
reduced the quantity of mitochondria (Figures 3B–E).
Propofol Alleviated High Levels of
Mitochondrial Fusion and Fission During
OGD/R in H9c2 Cells by Regulating
Mitochondrial Membrane Remodeling
Dynamin Family Proteins
It is well-accepted that Drp1 and Fis1 proteins promote
mitochondrial fission, whereas Mfn1, Mfn2 and Opa1 proteins
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FIGURE 2 | Propofol significantly inhibited H9c2 cells apoptosis induced by OGD/R injury. The cells were analyzed by flow cytometry. The data are presented as the
mean ± SD of at least three independent experiments. ∗∗P < 0.01 versus control, #P < 0.05, ##P < 0.01 versus OGD/R group without propofol.
mediate mitochondrial fusion. Furthermore, high expression of
Drp1, Mfn1 and Mfn2 may lead to cell death in the heart
(Whelan et al., 2012; Park et al., 2014). The experimental results
demonstrated that in the OGD/R group without propofol, the
levels of Drp1 and Fis1 proteins were significantly elevated
compared with the control group. Moreover, with the increase of
propofol concentration, the levels of Drp1 and Fis1 proteins were
significantly decreased during OGD/R injury (Figures 4A–C).
These results may suggest that propofol could inhibit the high
expression of mitochondrial fission proteins induced by OGD/R
injury. Compared with the control group, the levels of Mfn1 and
Mfn2 proteins were also significantly elevated during OGD/R
injury. Additionally, with the increase of propofol concentration,
the high levels of Mfn1 and Mfn2 proteins during OGD/R injury
were significantly decreased (Figures 4A,D,E). However, there
was no significant difference in the levels of Opa1 between
the control and OGD/R without propofol group. Propofol
did not influence the levels of Opa1 during OGD/R injury
(Figures 4A,F). Propofol may also inhibit the high levels of some
mitochondrial fusion proteins induced by OGD/R injury. The
experimental results demonstrated that mitochondrial fission
and mitochondrial fusion were significantly elevated by OGD/R
injury and were alleviated by propofol.
Mitochondrial Morphology and Quantity
Kept Stable and Propofol Inhibited Drp1
Colocalization With Mitochondria in
H9c2 Cells During OGD/R Injury
From the experimental results, we observed that the
mitochondrial morphology and quantity of H9c2 cells
remained stable among the control group, the OGD/R without
propofol group and the OGD/R with 20 µM propofol group
(Figures 5A,D,G,J,K). The result was consistent with the
levels of mitochondrial membrane remodeling dynamin family
proteins. Previous research has shown that Drp1 in other normal
cells distributed throughout the cytoplasm, with lower-levels
of colocalization with the mitochondria (Wang et al., 2015).
However, surprisingly we found that most Drp1 was collocated
with the mitochondria, or surrounded them in the H9c2 cells,
whether in the control or OGD/R groups (Figures 5C,F,I). But
there was a lower fluorescence signal for Drp1 in the control
group (Figure 5B), which was consistent with lower levels
of Drp1. Using 20 µM propofol treatment, there was more
Drp1 in the cytoplasm of the H9c2 cells during OGD/R injury,
compared with the group that received no propofol treatment
(Figures 5E,F,H,I). The results suggested that plenty of Drp1
colocalizing with mitochondria or by surrounding them, worked
in mitochondrial fission and propofol could significantly prevent
Drp1 from cytoplasm to mitochondria.
Propofol Could Inhibit Drp1
Phosphorylation Through Decreasing
ERK Activation During OGD/R
As previously reported, ERK is phosphorylated when oxidative
stress occurs, relating to apoptosis, but its mechanism remains
unclear (Kodiha et al., 2009; Rasola et al., 2010). The
experimental results demonstrated that during OGD/R, the levels
of pERK were significantly decreased by propofol in a dose-
dependent manner at the range of 10∼20 µM (Figures 6A,B).
Furthermore, U0126 can markedly inhibit ERK phosphorylation
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FIGURE 3 | Propofol inhibited mitochondrial fission in H9c2 cells during OGD injury. (A,B,D,E) Compared with control group, small mitochondria (green arrows)
increased in H9c2 cells during OGD injury. Scale bar: 10 µm. (B–E) Propofol increased the quantity and proportion of large mitochondria (red arrows) in H9c2 cells
during OGD injury. The data are presented as the mean ± SD of at least three independent experiments. ∗P < 0.05 versus control, #P < 0.05, versus OGD group
without propofol.
(Figures 6A,C). ERK1/2 have been reported to phosphorylate
Drp1 at serine 616, resulting in increased mitochondrial
fission (Qi et al., 2011; Yu et al., 2011; Strack et al., 2013).
The levels of pDrp1 (S616) during OGD/R were significantly
decreased by 20 µM propofol and U0126 (Figures 6A,D,F).
Mfn1 was also found to be phosphorylated by ERK, which
favored Bak oligomerization contributing to apoptosis (Pyakurel
et al., 2015). U0126 could not influence the higher levels
of Mfn1 in H9c2 cells induced by OGD/R (Figures 6A,E).
These results demonstrated that propofol could inhibit Drp1
phosphorylation in H9c2 cells by decreasing ERK activation
during OGD/R.
Propofol Ameliorated H9c2 Cells
Apoptosis During OGD/R via Inhibiting
Mitochondrial Cytochrome c Release,
Caspase-9, Caspase-6, Caspase-7, and
Caspase-3 Activation
As is the case for most cells, the mitochondrial pathway
(intrinsic pathway) is one of upstream apoptotic signaling.
It involves the sequential release of cytochrome c, the
recruitment of Apaf-1 (apoptotic protease-activating factor-
1), and the activation of caspase-9 and downstream executioner
caspases. The Bcl-2 family proapoptotic members Bax and
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FIGURE 4 | Propofol inhibited high expression of some mitochondrial dynamin family proteins induced by OGD/R in H9c2 cells. (A) Representative bands of Drp1,
Fis1, Mfn1, Mfn2 and Opa1 by western blotting. (B–E) With the increase of propofol concentration (5, 10, 20 µM), the levels of Drp1, Fis1, Mfn1 and Mfn2 protein
were significantly decreased during OGD/R injury. (F) However, there was no significant difference in the levels of Opa1 between control group and OGD/R group
with or without propofol. The data are presented as the mean ± SD of at least three independent experiments. ∗∗P < 0.01 versus control, #P < 0.05, ##P < 0.01
versus OGD/R group without propofol.
Bak can mediate MOMP, releasing cytochrome c, along
with other proapoptotic factors, into the cytosol (Frank
et al., 2001). In the control group the levels of Bax, Bak,
cytosol cytochrome c, Apaf-1, Cleaved caspase-9, Cleaved
caspase-6, Cleaved caspase-7 and Cleaved caspase-3 were
lower. Conversely, the levels of Bax, Bak, cytosol cytochrome
c, Apaf-1, Cleaved caspase-9, Cleaved caspase-6, Cleaved
caspase-7 and Cleaved caspase-3, were higher in the
OGD/R without propofol group. In addition, with the
increase of the propofol concentration (10, 20 µM), the
levels of Bax, Bak, cytosol cytochrome c, Apaf-1, Cleaved
caspase-9, Cleaved caspase-6, Cleaved caspase-7 and Cleaved
caspase-3, were markedly reduced during OGD/R injury
(Figures 7A–F,H–K). In the OGD/R without propofol
group, the level of mitochondrial cytochrome c protein
was significantly reduced compared with the control group.
But with the increase of the propofol concentration (10,
20 µM), the level of mitochondrial cytochrome c protein was
obviously elevated during OGD/R injury (Figures 7A,G).
The experimental results demonstrated that propofol could
ameliorate H9c2 cells apoptosis during OGD/R, via inhibiting
the intrinsic pathway.
DISCUSSION
In the present study, we found that propofol could inhibit
high levels of mitochondrial fission and fusion of the H9c2
cells, by regulating membrane remodeling dynamin family
proteins during OGD/R injury and then ameliorate H9c2 cells
apoptosis by the mitochondrial pathway. The concentration of
propofol was consistent with those of previous investigations
(Wang et al., 2009; Zhao et al., 2015). In our study, we
observed that propofol at a concentration of 5 to 20 µM,
significantly reduced cell death in a dose-dependent way and
attenuated the level of ROS during OGD/R injury, which
indicated that propofol had a strong protective effect against
oxidative stress induced by I/R injury in cardiac myocytes.
But when we treated H9c2 cells with propofol directly in a
normal cell culture for 24 h, cell proliferation was obviously
inhibited. And Z-VAD-FMK could relieve the decrease of cell
viability induced by 20 µM propofol. This suggested that the
protective effect of propofol was indeed due to the reduction
of OGD/R damage, rather than the higher proliferation of
the H9c2 cells during recovery. At the same time, it also
demonstrated that high concentrations of propofol could cause
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FIGURE 5 | Mitochondrial morphology and quantity kept stable and propofol inhibited Drp1 colocalization with mitochondria in H9c2 cells during OGD/R injury.
(A,D,G,J,K) Mitochondrial (red) morphology and quantity of H9c2 cells kept stable among control group, OGD/R group without propofol and OGD/R group with
20 µM propofol. Scale bar: 25 µm. (B,C) There was a lower fluorescence signal for Drp1 (green) and most Drp1 was collocated with the mitochondria or surrounded
them in control group. (E,H) The distribution of Drp1 in OGD/R group with 20 µM propofol was more diffuse than the distribution of it in OGD/R group without
propofol. (F) Plenty of Drp1 was collocated with mitochondria or surrounded them in OGD/R group without propofol. (I) Using 20 µM propofol treatment, Drp1
(green) was significantly prevented from cytoplasm to mitochondria during OGD/R injury. The data are presented as the mean ± SD of at least three independent
experiments.
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FIGURE 6 | Propofol could inhibit Drp1 phosphorylation through decreasing ERK activation in H9c2 cells during OGD/R. (A) Representative bands of pERK, ERK,
pDrp1, Drp1 and Mfn1 by western blotting. (B) With the increase of propofol concentration (10, 20 µM), the levels of pERK were significantly decreased during
OGD/R injury. (C) U0126 can markedly inhibit ERK phosphorylation. (D,F) The levels of pDrp1 (S616) during OGD/R were significantly decreased by 20 µM propofol
and U0126. (E) There was no significant difference in the levels of Mfn1 between OGD/R group without propofol and OGD/R group with U0126. The data are
presented as the mean ± SD of at least three independent experiments. ∗∗P < 0.01 versus control, #P < 0.05, ##P < 0.01 versus OGD/R group without propofol.
damage to the H9c2 cells by activating caspases. As the
concentration of propofol went up, propofol alleviated cell
apoptosis induced by OGD/R in a dose-dependent manner, at
the range of 5∼20 µM. Therefore, we further explored the
mechanism of propofol inhibiting H9c2 cells apoptosis induced
by OGD/R injury.
Previous studies showed that altering mitochondrial
morphology affected cell apoptosis. Studies indicated that
mitochondria underwent fission when HL-1 cardiac cells
were subjected to simulated ischemia, generating fragmented
mitochondria (Brady et al., 2006). We also observed that
mitochondrial fission was obvious in H9c2 cells during
OGD injury and propofol could significantly inhibited it.
Mitochondrial ROS, which is generated during acute I/R injury
is known to induce mitochondrial fission (Plotnikov et al., 2008).
In our study, the level of ROS was higher in H9c2 cells during
OGD/R injury. In the OGD/R without propofol group, the
levels of Drp1, Fis1, Mfn1 and Mfn2 protein were significantly
elevated compared with the control group. With the increase
of propofol concentration (5, 10, 20 µM), the high levels of
Drp1, Fis1, Mfn1 and Mfn2 protein during OGD/R injury
were significantly decreased. The experimental results might
demonstrate that mitochondrial fission and mitochondrial
fusion were significantly elevated by OGD/R injury and were
alleviated by propofol. In mitochondrial staining we observed
that mitochondrial morphology and the quantity of H9c2 cells,
remained stable in the control, OGD/R without propofol and
OGD/R groups with 20 µM propofol. The result was consistent
with the levels of mitochondrial membrane remodeling dynamin
family proteins. Though mitochondrial fission was obvious in
H9c2 cells during OGD injury, mitochondrial morphology and
the quantity of H9c2 cells remained stable during OGD/R injury.
This difference may be due to a high level of mitochondrial
fusion during reperfusion.
It has been reported that propofol increases both the activities
and protein expressions of superoxide dismutase and catalase
to reduce intracellular ROS (Zhao et al., 2015). Additionally,
it has been shown that mitochondrial fission induced by
Drp1 could reduce inner membrane proton leak/uncoupling
in other cell types, contributing to ROS production from
mitochondria (Galloway et al., 2012a; Wang et al., 2015).
Thus, propofol may reduce ROS production in H9c2 cells by
decreasing the levels of Drp1 during OGD/R injury. ERK1/2
can be phosphorylated when oxidative stress occurs, which
further phosphorylates Drp1 at serine 616, resulting in increased
mitochondrial fission (Kodiha et al., 2009; Yu et al., 2011).
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FIGURE 7 | Propofol ameliorated H9c2 cells apoptosis during OGD/R via inhibiting intrinsic apoptosis pathway. (A,H) Representative bands of Bax, Bak, cytosol
cytochrome c, Apaf-1, caspase-9, mitochondrial cytochrome c, caspase-6, caspase-7, and caspase-3 by western blotting. (B,C,E,J) With the increase of propofol
concentration (5, 10, 20 µM), the levels of Bax, Bak, Apaf-1, and Cleaved caspase-7 were gradually reduced during OGD/R injury. (D,F,I,K) While the levels of cytosol
cytochrome c, Cleaved caspase-9, Cleaved caspase-6 and Cleaved caspase-3 were markedly inhibited by 10 and 20 µM propofol during OGD/R injury. (G) And
with the increase of propofol concentration (10, 20 µM), the level of mitochondrial cytochrome c protein was obviously elevated during OGD/R injury. The data are
presented as the mean ± SD of at least three independent experiments. ∗∗P < 0.01 versus control, #P < 0.05, ##P < 0.01 versus OGD/R group without propofol.
Our results demonstrated that in immunofluorescence, plenty
of Drp1 colocalizing with mitochondria or by surrounding
them, worked in mitochondrial fission. Moreover, propofol could
inhibit Drp1 phosphorylation at serine 616 in H9c2 cells by
decreasing ERK activation during OGD/R, thus resulting in
inhibiting mitochondrial fission.
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FIGURE 8 | Diagram of mitochondrial dynamics regulating intrinsic apoptosis
pathway.
A previous study also showed that genetic inhibition of Drp1
in HL-1 cardiac cells, not only inhibited the mitochondrial
fission induced by acute I/R injury but also reduced cell death
in this setting (Ong et al., 2010). Drp1 has been demonstrated
to co-localize with Bax at the outer mitochondrial membrane
in response to apoptotic stimuli (Karbowski et al., 2002). Bax
assembles with Bak and Drp1 in the form of a ring, to
delineate the area required for MOMP (Grosse et al., 2016).
Interestingly, we found that propofol could inhibit the high
expression of Drp1, Fis1, Bax and Bak proteins induced by
OGD/R injury. Fis1 has been demonstrated to promote the
migration of Drp1 to mitochondria in the cytoplasm (Stojanovski
et al., 2004). We observed that in immunofluorescence, propofol
can significantly prevent Drp1 from cytoplasm to mitochondria
during OGD/R injury. Therefore, propofol could reduce Drp1
colocalization with mitochondria by lowering levels of Drp1 and
Fis1. Propofol may inhibit outer membrane permeabilization
by reducing the high levels of Drp1, Bax and Bak during
OGD/R injury.
When Mfn1 is phosphorylated by ERK, mitochondria
fragment and Bak oligomerization is favored, therefore
cytochrome c release and cell death (Pyakurel et al., 2015).
Our results demonstrated that propofol could significantly
decrease ERK activation in H9c2 cells during OGD/R injury.
U0126 did not influence the higher levels of non-phosphorylated
Mfn1 in H9c2 cells induced by OGD/R. We speculate that
propofol could still inhibit Mfn1 phosphorylation in H9c2
cells, by decreasing ERK activation during OGD/R injury. In
the heart, acceleration of Mfn1 degradation by membrane-
associated RING-CH (MARCH5) under stress, remains an
important quality control system that inhibits cell death (Park
et al., 2014). Oxidative stress with H2O2 leads to concurrent
increases in Mfn2 expression and apoptosis in cultured neonatal
rat cardiomyocytes, and Mfn2 silencing inhibits oxidative
stress-induced apoptosis in H9c2 cells. Mfn2 also suppresses
phosphatidylinositol 3 kinase-protein kinase B (PI3K-Akt)
cell survival signaling pathways (Shen et al., 2007). Mfn2 has
been demonstrated to co-localize with both Bax and Bak in
the outer mitochondrial membrane (Neuspiel et al., 2005). Our
data indicated that propofol could inhibit the high expression
of the Mfn1 and Mfn2 protein induced by OGD/R injury.
OPA1 mediates mitochondrial inner membrane fusion and
regulates mitochondrial cristae morphology (Olichon et al.,
2003; Cipolat et al., 2004). Anti-apoptotic effects of Opa1 have
been attributed to its role in regulating mitochondrial cristae
morphology and cytochrome c distribution (Korwitz et al., 2016).
However, in our study, propofol did not influence the levels
of Opa1 during OGD/R injury and there were no significant
changes of Opa1 in OGD/R injury. This could be because
the H9c2 cells were less damaged, which did not damage the
mitochondrial inner membrane, but affected the mitochondrial
outer membrane.
To further test that propofol inhibits higher outer
mitochondrial membrane permeabilization induced by
OGD/R injury, we measured the levels of cytochrome c in
the cytoplasm or mitochondria. Our results indicated that
cytochrome c was released into the cytoplasm and the process
was inhibited by propofol during OGD/R injury. Cytochrome
c, Apaf-1 and procaspase-9 in the cytoplasm combine to
form the apoptosome, which leads to procaspase-9 activation
(Srinivasula et al., 1998; Zhang et al., 2002). Active caspase-9
then activates the executioner caspase-3, -6, and -7 to complete
apoptosis. We found that the expression levels of Apaf-1
and the activities of caspase-9, -3, -6, and -7 were higher in
H9c2 cells during OGD/R injury, which could be reversed
by propofol. This demonstrated that propofol could reduce
H9c2 cells apoptosis during OGD/R injury by inhibiting
the mitochondria pathway, which was due to reducing high
levels of mitochondrial fusion and fission induced by OGD/R
injury (Figure 8).
However, all our experimental results were limited to the level
of cells in vitro, and the study on the regulation of propofol
on mitochondrial morphology was limited to the regulation
of the protein level. Further animal experiments need to be
conducted to verify our experimental results, and the effect of
propofol on mitochondrial fusion and fission may be studied
from other regulatory levels. In short, our study may reveal
a new cardioprotective mechanism of propofol during acute
ischemia/reperfusion injury.
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